Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dalfampridine Combined With Physical Therapy for Mobility Impairment in People With Multiple Sclerosis

NCT06136728 is registered in ClinicalTrials.gov with MGH Institute of Health Professions as lead sponsor.

NCT NCT06136728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06136728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dalfampridine Combined With Physical Therapy for Mobility Impairment in People With Multiple Sclerosis
Lead sponsor
MGH Institute of Health Professions
Phase
Phase 3
Overall status
Recruiting
Start date
June 12, 2024
Completion date
December 31, 2026
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis